Clopidogrel Bisulphate IR Pellets Manufacturer in India

Clopidogrel Bisulphate IR Pellets – Pharmaceutical-Grade Immediate-Release Pellets

Clopidogrel Bisulphate IR Pellets are pharmaceutical-grade immediate-release multiparticulate pellets containing Clopidogrel Bisulphate as the active ingredient. Clopidogrel Bisulphate has CAS Number 120202-66-6, molecular formula C₁₆H₁₆ClNO₂S·H₂SO₄, and molecular weight 419.90 g/mol. The current USP monograph specifies 97.0–101.5% Clopidogrel Bisulphate, calculated on the dried basis.

The immediate-release pellet format provides a multiparticulate platform for oral formulation development. Active loading, pellet size, moisture, physical characteristics and dissolution are controlled according to the finished-product specification. The format can be used for capsule-filling and other multiparticulate formulation applications.

A commercial pharmaceutical pellet portfolio specifically lists Clopidogrel Bisulphate IR Pellets at 50% w/w strength. For the SDP website, this 50% strength should be published only if it corresponds to the current SDP specification/COA.

Key Features

• Pharmaceutical-grade Clopidogrel Bisulphate IR Pellets
• Active ingredient: Clopidogrel Bisulphate
• 50% w/w commercial reference strength
• Immediate-release multiparticulate format
• Suitable for capsule-filling applications
• Product-specific active loading
• Controlled pellet size and physical characteristics
• Product-specific dissolution profile
• Suitable for formulation development
• Suitable for bulk pharmaceutical manufacturing

Applications

Immediate-Release Oral Formulations

Clopidogrel Bisulphate IR Pellets are designed for immediate-release multiparticulate oral formulations.

Capsule Filling

The pellet format is suitable for incorporation into capsule dosage forms according to the selected active loading and formulation specification.

Multiparticulate Formulation Development

Individual pellets provide a flexible intermediate for development of oral multiparticulate formulations.

Pharmaceutical Manufacturing

The pellets can be used as a formulation intermediate where controlled active loading, pellet characteristics and immediate-release performance are required.

Bulk Pharmaceutical Supply

Clopidogrel Bisulphate IR Pellets can be supplied in bulk according to the approved finished-product specification.

Why Clopidogrel Bisulphate IR Pellets from Swapnroop?

• Pharmaceutical-Grade Pellets – Designed for pharmaceutical formulation applications.
• Immediate-Release Format – Designed for rapid release of the active ingredient.
• Product-Specific Active Loading – Clopidogrel Bisulphate concentration is controlled according to the applicable specification.
• 50% Commercial Reference Strength – A 50% w/w strength is documented for commercial Clopidogrel Bisulphate IR Pellets. 
• Multiparticulate Format – Suitable for capsule filling and oral multiparticulate formulations.
• Controlled Pellet Characteristics – Pellet size, moisture, assay and dissolution can be controlled according to the approved specification.
• Formulation Flexibility – Suitable for immediate-release formulation development.
• Bulk Pharmaceutical Supply – Suitable for pharmaceutical manufacturers requiring bulk pellet intermediates.
• Clopidogrel Pellet Supplier Support – Product and supply parameters can be aligned with customer formulation requirements.

Get Bulk Quote via WhatsApp